Rare germline mutations in the TP53 gene cause Li-Fraumeni syndrome with highly increased risk for various malignancies, including breast cancer [5]; whereas a common TP53 variant in the population, R72P with functional effect on p53 protein, has been shown to affect breast cancer survival [6,7]. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.